Recent advances in mesenchymal stem cell immunomodulation: The role of microvesicles

Cell Transplantation

Volumn 24, Issue 2, 2015, Pages 133-149

  Fierabracci, Alessandra ^a   Del Fattore, Andrea ^a   Luciano, Rosa ^a   Muraca, Marta ^b   Teti, Anna ^c   Muraca, Maurizio ^d  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Exosomes; Immunity; Mesenchymal stem cells; Microvesicles

Indexed keywords

CELL COMMUNICATION; CELL COMPOSITION; CELL REGENERATION; CELL VACUOLE; EXOSOME; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; ADVERSE EFFECTS; ANIMAL; AUTOIMMUNE DISEASE; CLINICAL TRIAL (TOPIC); CYTOLOGY; GRAFT VS HOST DISEASE; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; T LYMPHOCYTE;

ANIMALIA;

ANIMALS; AUTOIMMUNE DISEASES; CLINICAL TRIALS AS TOPIC; EXOSOMES; GRAFT VS HOST DISEASE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; REGENERATIVE MEDICINE; T-LYMPHOCYTES;

EID: 84923204009     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368913X675728     Document Type: Review

References (188)

1. Admyre, C.; Grunewald, J.; Thyberg, J.; Gripenback, S.; Tornling, G.; Eklund, A.; Scheynius, A.; Gabrielsson, S. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur. Respir. J. 22(4):578-583; 2003.
2. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4):1815-1822; 2005.
3. Agung, M.; Ochi, M.; Yanada, S.; Adachi, N.; Izuta, Y.; Yamasaki, T.; Toda, K. Mobilization of bone marrowderived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg. Sports Traumatol. Arthrosc. 14(12): 1307-1314; 2006.
4. Ahmad, A. Grafix® demonstrates overwhelming efficacy in landmark stem cell study for the treatment of diabetic foot ulcers; 2013. Available from http://www.osiris.com?2013-08-13%20Grafix%20DFU%20Trial%20Results.pdf
5. Akiyama, K.; Chen, C.; Wang, D.; Xu, X.; Qu, C.; Yamaza, T.; Cai, T.; Chen, W.; Sun, L.; Shi, S. Mesenchymalstem-cell-induced immunoregulation involves FAS-ligand-?FAS-mediated T cell apoptosis. Cell Stem Cell 10(5):544-555; 2012.
6. Aline, F.; Bout, D.; Amigorena, S.; Roingeard, P.; Dimier-Poisson, I. Toxoplasma gondii antigen-pulsed-dendritic cellderived exosomes induce a protective immune response against T. gondii infection. Infect. Immun. 72(7):4127-4137; 2004.
7. Al-Nedawi, K.; Meehan, B.; Kerbel, R. S.; Allison, A. C.; Rak, J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl. Acad. Sci. USA 106(10):3794-3799; 2009.
8. Al-Nedawi, K.; Meehan, B.; Micallef, J.; Lhotak, V.; May, L.; Guha, A.; Rak, J. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10(5):619-624; 2008.
9. Amsalem, Y.; Mardor, Y.; Feinberg, M. S.; Landa, N.; Miller, L.; Daniels, D.; Ocherashvilli, A.; Holbova, R.; Yosef, O.; Barbash, I. M.; Leor, J. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 116(11 Suppl):38-45; 2007.
10. Andreola, G.; Rivoltini, L.; Castelli, C.; Huber, V.; Perego, P.; Deho, P.; Squarcina, P.; Accornero, P.; Lozupone, F.; Lugini, L.; Stringaro, A.; Molinari, A.; Arancia, G.; Gentile, M.; Parmiani, G.; Fais, S. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195(10):1303-1316; 2002.
11. Ashiru, O.; Boutet, P.; Fernandez-Messina, L.; Aguera-Gonzalez, S.; Skepper, J. N.; Vales-Gomez, M.; Reyburn, H. T. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res. 70(2):481-489; 2010.
12. Augello, A.; Tasso, R.; Negrini, S. M.; Amateis, A.; Indiveri, F.; Cancedda, R.; Pennesi, G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 35(5):1482-1490; 2005.
13. Augello, A.; Tasso, R.; Negrini, S. M.; Cancedda, R.; Pennesi, G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 56(4):1175-1186; 2007.
14. Bai, L.; Lennon, D. P.; Eaton, V.; Maier, K.; Caplan, A. I.; Miller, S. D.; Miller, R. H. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57(11):1192-1203; 2009.
15. Baker, M. Stem-cell drug fails crucial trials. Nature http:/?www.nature.com/news/2009/090909/full/news.2009.894.htm; 2009.
16. Banerjee, M.; Kumar, A.; Bhonde, R. R. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem. Biophys. Res. Commun. 328(1):318-325; 2005.
17. Barres, C.; Blanc, L.; Bette-Bobillo, P.; Andre, S.; Mamoun, R.; Gabius, H. J.; Vidal, M. Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages. Blood 115(3):696-705; 2010.
18. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30(1): 42-48; 2002.
19. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z.; Aslan, H.; Galun, E.; Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105(5): 2214-2219; 2005.
20. Bhatnagar, S.; Schorey, J. S. Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J. Biol. Chem. 282(35): 25779-25789; 2007.
21. Bruno, S.; Grange, C.; Deregibus, M. C.; Calogero, R. A.; Saviozzi, S.; Collino, F.; Morando, L.; Busca, A.; Falda, M.; Bussolati, B.; Tetta, C.; Camussi, G. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20(5):1053-1067; 2009.
22. Budoni, M.; Fierabracci, A.; Luciano, R.; Petrini, S.; Di Ciommo, V.; Muraca, M. The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles. Cell Transplant. 22(2):369-379; 2013.
23. Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213(2):341-347; 2007.
24. Chamberlain, G.; Fox, J.; Ashton, B.; Middleton, J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11):2739-2749; 2007.
25. Chang, J. W.; Hung, S. P.; Wu, H. H.; Wu, W. M.; Yang, A. H.; Tsai, H. L.; Yang, L. Y.; Lee, O. K. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 20(2):245-257; 2011.
26. Chaput, N.; Schartz, N. E. C.; Andre, F.; Taieb, J.; Novault, S.; Bonnaventure, P.; Aubert, N.; Bernard, J.; Lemonnier, F.; Merad, M.; Adema, G.; Adams, M.; Ferrantini, M.; Carpentier, A. F.; Escudier, B.; Tursz, T.; Angevin, E.; Zitvogel, L. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 172(4):2137-2146; 2004.
27. Chaput, N.; Thery, C. Exosomes: Immune properties and potential clinical implementations. Semin. Immunopathol. 33(5):419-440; 2011.
28. Chen, C.; Skog, J.; Hsu, C. H.; Lessard, R. T.; Balaj, L.; Wurdinger, T.; Carter, B. S.; Breakefield, X. O.; Toner, M.; Irimia, D. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab. Chip 10(4):505-511; 2010.
29. Chen, T. S.; Arslan, F.; Yin, Y.; Tan, S. S.; Lai, R. C.; Choo, A. B. H.; Padmanabhan, J.; Lee, C. N.; de Kleijn, D. P. V.; Lim, S. K. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J. Transl. Med. 9:47; 2011.
30. Chen, W.; Li, M.; Li, Z.; Yan, Z.; Cheng, H.; Pan, B.; Cao, J.; Chen, C.; Zeng, L.; Xu, K. CXCR4-transduced mesenchymal stem cells protect mice against graft-versushost disease. Immunol. Lett. 143(2):161-169; 2012.
31. Chhabra, P.; Brayman, K. L. Stem cell therapy to cure type 1 diabetes: From hype to hope. Stem Cells Transl. Med. 2(5):328-336; 2013.
32. Choi, J. B.; Uchino, H.; Azuma, K.; Iwashita, N.; Tanaka, Y.; Mochizuki, H.; Migita, M.; Shimada, T.; Kawamori, R.; Watada, H. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 46(10):1366-1374; 2003.
33. Choi, M. R.; Kim, H. Y.; Park, J. Y.; Lee, T. Y.; Baik, C. S.; Chai, Y. G.; Jung, K. H.; Park, K. S.; Roh, W.; Kim, K. S.; Kim, S. H. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. Neurosci. Lett. 472(2):94-98; 2010.
34. Christopeit, M.; Schendel, M.; Foll, J.; Muller, L. P.; Keysser, G.; Behre, G. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidenticalrelated donor mediated by ligation of CD137L. Leukemia 22(5):1062-1064; 2008.
35. Clayton, A.; Court, J.; Navabi, H.; Adams, M.; Mason, M. D.; Hobot, J. A.; Newman, G. R.; Jasani, B. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods 247(1-2):163-174; 2001.
36. Clayton, A.; Mitchell, J. P.; Court, J.; Mason, M. D.; Tabi, Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 67(15): 7458-7466; 2007.
37. Clifford, D. M.; Fisher, S. A.; Brunskill, S. J.; Doree, C.; Mathur, A.; Clarke, M. J.; Watt, S. M.; Martin-Rendon, E. Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: Factors that may influence outcomes. PLoS One 7(5):e37373; 2012.
38. Cocucci, E.; Racchetti, G.; Meldolesi, J. Shedding microvesicles: Artefacts no more. Trends Cell Biol. 19(2): 43-51; 2009.
39. Cocucci, E.; Racchetti, G.; Podini, P.; Meldolesi, J. Enlargeosome traffic: Exocytosis triggered by various signals is followed by endocytosis, membrane shedding or both. Traffic 8(6):742-757; 2007.
40. Collino, F.; Deregibus, M. C.; Bruno, S.; Sterpone, L.; Aghemo, G.; Viltono, L.; Tetta, C.; Camussi, G. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5(7):e11803; 2010.
41. Comoli, P.; Ginevri, F.; Maccario, R.; Avanzini, M. A.; Marconi, M.; Groff, A.; Cometa, A.; Cioni, M.; Porretti, L.; Barberi, W.; Frassoni, F.; Locatelli, F. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol. Dial. Transplant. 23(4): 1196-1202; 2008.
42. Connick, P.; Kolappan, M.; Patani, R.; Scott, M. A.; Crawley, C.; He, X.-L.; Richardson, K.; Barber, K.; Webber, D. J.; Wheeler-Kingshott, C. A. M.; Tozer, D. J.; Samson, R. S.; Thomas, D. L.; Du, M.-Q.; Luan, S. L.; Michell, A. W.; Altmann, D. R.; Thompson, A. J.; Miller, D. H.; Compston, A.; Chandran, S. The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: An open-label pre-test: Post-test study with blinded outcome assessments. Trials 12:62; 2011.
43. Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G. L.; Pistoia, V.; Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107(1): 367-372; 2006.
44. Davatchi, F.; Abdollahi, B. S.; Mohyeddin, M.; Shahram, F.; Nikbin, B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int. J. Rheum. Dis. 14(2):211-215; 2011.
45. De Bari, C.; Dell’Accio, F.; Tylzanowski, P.; Luyten, F. P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44(8):1928-1942; 2001.
46. Del Fattore, A.; Luciano, R.; Fierabracci, A.; Muraca, M. Microvesicles derived from mesenchymal stem cells show anti-inflammatory activity in an animal model of ulcerative colitis. 5th Meeting of the Forum of Italian Researchers on Mesenchymal and Stromal Stem Cells. Milan, Italy; 2013.
47. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P. D.; Matteucci, P.; Grisanti, S.; Gianni, A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10):3838-3843; 2002.
48. Djouad, F.; Fritz, V.; Apparailly, F.; Louis-Plence, P.; Bony, C.; Sany, J.; Jorgensen, C.; Noel, D. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 52(5):1595-1603; 2005.
49. Dominici, M.; Le Blanc, K.; Mueller, I.; SlaperCortenbach, I.; Marini, F. C.; Krause, D. S.; Deans, R. J.; Keating, A.; Prockop, D.; Em, H. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
50. Dorshkind, K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu. Rev. Immunol. 8: 111-137; 1990.
51. Duijvestein, M.; Vos, A. C. W.; Roelofs, H.; Wildenberg, M. E.; Wendrich, B. B.; Verspaget, H. W.; Kooy-Winkelaar, E. M. C.; Koning, F.; Zwaginga, J. J.; Fidder, H. H.; Verhaar, A. P.; Fibbe, W. E.; van den Brink, G. R.; Hommes, D. W. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: Results of a phase I study. Gut 59(12):1662-1669; 2010.
52. Eggenhofer, E.; Benseler, V.; Kroemer, A.; Popp, F. C.; Geissler, E. K.; Schlitt, H. J.; Baan, C. C.; Dahlke, M. H.; Hoogduijn, M. J. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front. Immunol. 3:297; 2012.
53. English, K.; French, A.; Wood, K. J. Mesenchymal stromal cells: Facilitators of successful transplantation? Cell Stem Cell 7(4):431-442; 2010.
54. Erices, A.; Conget, P.; Minguell, J. J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109(1):235-242; 2000.
55. Escudier, B.; Dorval, T.; Chaput, N.; Andre, F.; Caby, M. P.; Novault, S.; Flament, C.; Leboulaire, C.; Borg, C.; Amigorena, S.; Boccaccio, C.; Bonnerot, C.; Dhellin, O.; Movassagh, M.; Piperno, S.; Robert, C.; Serra, V.; Valente, N.; Le Pecq, J. B.; Spatz, A.; Lantz, O.; Tursz, T.; Angevin, E.; Zitvogel, L. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: Results of the first phase I clinical trial. J. Transl. Med. 3(1):10; 2005.
56. Ezquer, F. E.; Ezquer, M. E.; Parrau, D. B.; Carpio, D.; Yanez, A. J.; Conget, P. A. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol. Blood Marrow Transplant. 14(6):631-640; 2008.
57. Figueroa, F. E.; Carrión, F.; Villanueva, S.; Khoury, M. Mesenchymal stem cell treatment for autoimmune diseases: A critical review. Biol. Res. 45:269-277; 2012.
58. Fiorina, P.; Jurewicz, M.; Augello, A.; Vergani, A.; Dada, S.; La Rosa, S.; Selig, M.; Godwin, J.; Law, K.; Placidi, C.; Smith, R. N.; Capella, C.; Rodig, S.; Adra, C. N.; Atkinson, M.; Sayegh, M. H.; Abdi, R. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J. Immunol. 183(2):993-1004; 2009.
59. Friedenstein, A. J.; Piatetzky-Shapiro, I. I.; Petrakova, K. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16(3):381-390; 1996.
60. Garcia-Olmo, D.; Garcia-Arranz, M.; Herreros, D.; Pascual, I.; Peiro, C.; Rodriguez-Montes, J. A. A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum 48(7):1416-1423; 2005.
61. Garcia-Olmo, D.; Herreros, D.; Pascual, I.; Pascual, J. A.; Del-Valle, E.; Zorrilla, J.; De-La-Quintana, P.; Garcia-Arranz, M.; Pascual, M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: A phase II clinical trial. Dis. Colon Rectum 52(1):79-86; 2009.
62. Glennie, S.; Soeiro, I.; Dyson, P. J.; Lam, E. W. F.; Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105(7):2821-2827; 2005.
63. Gregoire-Gauthier, J.; Selleri, S.; Fontaine, F.; Dieng, M. M.; Patey, N.; Despars, G.; Beausejour, C. M.; Haddad, E. Therapeutic efficacy of cord blood-derived mesenchymal stromal cells for the prevention of acute graft-versus-host disease in a xenogenic mouse model. Stem Cells Dev. 21(10):1616-1626; 2012.
64. Gronthos, S.; Mankani, M.; Brahim, J.; Robey, P. G.; Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA 97(25):13625-13630; 2000.
65. Gu, Z.; Akiyama, K.; Ma, X.; Zhang, H.; Feng, X.; Yao, G.; Hou, Y.; Lu, L.; Gilkeson, G. S.; Silver, R. M.; Zeng, X.; Shi, S.; Sun, L. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19(13):1502-1514; 2010.
66. Guadalajara, H.; Herreros, D.; De-La-Quintana, P.; Trebol, J.; Garcia-Arranz, M.; Garcia-Olmo, D. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int. J. Colorectal Dis. 27(5):595-600; 2012.
67. Hanayama, R.; Tanaka, M.; Miwa, K.; Shinohara, A.; Iwamatsu, A.; Nagata, S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417(6885):182-187; 2002.
68. Hare, J. M.; Traverse, J. H.; Henry, T. D.; Dib, N.; Strumpf, R. K.; Schulman, S. P.; Gerstenblith, G.; DeMaria, A. N.; Denktas, A. E.; Gammon, R. S.; Hermiller, J. B.; Reisman, M. A.; Schaer, G. L.; Sherman, W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54(24):2277-2286; 2009.
69. Hasegawa, Y.; Ogihara, T.; Yamada, T.; Ishigaki, Y.; Imai, J.; Uno, K.; Gao, J.; Kaneko, K.; Ishihara, H.; Sasano, H.; Nakauchi, H.; Oka, Y.; Katagiri, H. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology 148(5):2006-2015; 2007.
70. Hass, R.; Kasper, C.; Bohm, S.; Jacobs, R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 9:12; 2011.
71. Hedlund, M.; Stenqvist, A. C.; Nagaeva, O.; Kjellberg, L.; Wulff, M.; Baranov, V.; Mincheva-Nilsson, L. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: Evidence for immunosuppressive function. J. Immunol. 183(1):340-351; 2009.
72. Herreros, M. D.; Garcia-Arranz, M.; Guadalajara, H.; De-La-Quintana, P.; Garcia-Olmo, D. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: A phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Dis. Colon Rectum 55(7):762-772; 2012.
73. Honmou, O.; Houkin, K.; Matsunaga, T.; Niitsu, Y.; Ishiai, S.; Onodera, R.; Waxman, S. G.; Kocsis, J. D. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134(Pt 6): 1790-1807; 2011.
74. Horie, M.; Sekiya, I.; Muneta, T.; Ichinose, S.; Matsumoto, K.; Saito, H.; Murakami, T.; Kobayashi, E. Intra-articular injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect. Stem Cells 27(4):878-887; 2009.
75. Horwitz, E. M.; Dominici, M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 10(8):771-774; 2008.
76. Hsu, D. H.; Paz, P.; Villaflor, G.; Rivas, A.; Mehta-Damani, A.; Angevin, E.; Zitvogel, L.; Le Pecq, J. B. Exosomes as a tumor vaccine: Enhancing potency through direct loading of antigenic peptides. J. Immunother. 26(5): 440-450; 2003.
77. Huber, V.; Fais, S.; Iero, M.; Lugini, L.; Canese, P.; Squarcina, P.; Zaccheddu, A.; Colone, M.; Arancia, G.; Gentile, M.; Seregni, E.; Valenti, R.; Ballabio, G.; Belli, F.; Leo, E.; Parmiani, G.; Rivoltini, L. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: Role in immune escape. Gastroenterology 128(7):1796-1804; 2005.
78. Ianus, A.; Holz, G. G.; Theise, N. D.; Hussain, M. A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 111(6):843-850; 2003.
79. Iero, M.; Valenti, R.; Huber, V.; Filipazzi, P.; Parmiani, G.; Fais, S.; Rivoltini, L. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 15(1):80-88; 2008.
80. In’t Anker, P. S.; Scherjon, S. A.; Kleijburg van der Keur, C.; de Groot-Swings, G. M. J. S.; Claas, F. H. J.; Fibbe, W. E.; Kanhai, H. H. H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22(7):1338-1345; 2004.
81. Jang, M. J.; Kim, H.-S.; Lee, H.-G.; Kim, G. J.; Jeon, H. G.; Shin, H.-S.; Chang, S.-K.; Hur, G.-H.; Chong, S. Y.; Oh, D.; Chung, H.-M. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice. Acta Haematol. 129(4):197-206; 2013.
82. Johnson, K.; Zhu, S.; Tremblay, M. S.; Payette, J. N.; Wang, J.; Bouchez, L. C.; Meeusen, S.; Althage, A.; Cho, C. Y.; Wu, X.; Schultz, P. G. A stem cell-based approach to cartilage repair. Science 336(6082):717-721; 2012.
83. Karussis, D.; Karageorgiou, C.; Vaknin-Dembinsky, A.; Gowda-Kurkalli, B.; Gomori, J. M.; Kassis, I.; Bulte, J. W. M.; Petrou, P.; Ben-Hur, T.; Abramsky, O.; Slavin, S. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67(10):1187-1194; 2010.
84. Keating, A. Mesenchymal stromal cells: New directions. Cell Stem Cell 10(6):709-716; 2012.
85. Kebriaei, P.; Isola, L.; Bahceci, E.; Holland, K.; Rowley, S.; McGuirk, J.; Devetten, M.; Jansen, J.; Herzig, R.; Schuster, M.; Monroy, R.; Uberti, J. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol. Blood Marrow Transplant. 15(7):804-811; 2009.
86. Kerby, A.; Jones, E. S.; Jones, P. M.; King, A. J. Co-transplantation of islets with mesenchymal stem cells in microcapsules demonstrates graft outcome can be improved in an isolated-graft model of islet transplantation in mice. Cytotherapy 15(2):192-200; 2013.
87. Kim, S.-H.; Lechman, E. R.; Bianco, N.; Menon, R.; Keravala, A.; Nash, J.; Mi, Z.; Watkins, S. C.; Gambotto, A.; Robbins, P. D. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collageninduced arthritis. J. Immunol. 174(10):6440-6448; 2005.
88. Kitazawa, Y.; Li, X.-K.; Xie, L.; Zhu, P.; Kimura, H.; Takahara, S. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats. Cell Transplant. 21(2-3):581-590; 2012.
89. Klibi, J.; Niki, T.; Riedel, A.; Pioche-Durieu, C.; Souquere, S.; Rubinstein, E.; Le Moulec, S.; Moulec, S. L. E.; Guigay, J.; Hirashima, M.; Guemira, F.; Adhikary, D.; Mautner, J.; Busson, P. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113(9):1957-1966; 2009.
90. Krampera, M.; Cosmi, L.; Angeli, R.; Pasini, A.; Liotta, F.; Andreini, A.; Santarlasci, V.; Mazzinghi, B.; Pizzolo, G.; Vinante, F.; Romagnani, P.; Maggi, E.; Romagnani, S.; Annunziato, F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24(2):386-398; 2006.
91. Kronsteiner, B.; Peterbauer-Scherb, A.; Grillari-Voglauer, R.; Redl, H.; Gabriel, C.; van Griensven, M.; Wolbank, S. Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation. Cell. Immunol. 267(1):30-38; 2011.
92. Lai, R. C.; Arslan, F.; Lee, M. M.; Sze, N. S. K.; Choo, A.; Chen, T. S.; Salto-Tellez, M.; Timmers, L.; Lee, C. N.; El Oakley, R. M.; Pasterkamp, G.; de Kleijn, D. P. V.; Lim, S. K. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4(3):214-222; 2010.
93. Lamparski, H. G.; Metha-Damani, A.; Yao, J.-Y.; Patel, S.; Hsu, D.-H.; Ruegg, C.; Le Pecq, J.-B. Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods 270(2):211-226; 2002.
94. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Pasterkamp, G.; de Kleijn, D. P. V.; Lim, S. K. Mesenchymal stem cells for treatment of steroidresistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371(9624):1579-1586; 2008.
95. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Gotherstrom, C.; Hassan, M.; Uzunel, M.; Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363(9419): 1439-1441; 2004.
96. Lechner, A.; Yang, Y.-G.; Blacken, R. A.; Wang, L.; Nolan, A. L.; Habener, J. F. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 53(3):616-623; 2004.
97. Lee, C.; Mitsialis, S. A.; Aslam, M.; Vitali, S. H.; Vergadi, E.; Konstantinou, G.; Sdrimas, K.; Fernandez-Gonzalez, A.; Kourembanas, S. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126(22):2601-2611; 2012.
98. Lee, C. C.; Christensen, J. E.; Yoder, M. C.; Tarantal, A. F. Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. Exp. Hematol. 38(1):46-54; 2010.
99. Lee, R. H.; Seo, M. J.; Reger, R. L.; Spees, J. L.; Pulin, A. A.; Olson, S. D.; Prockop, D. J. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 103(46):17438-17443; 2006.
100. Lim, J. H.; Lee, M. H.; Yi, H. G.; Kim, C. S.; Kim, J. H.; Song, S. U. Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: A report of two cases. Int. J. Hematol. 92(1):204-207; 2010.
101. Liu, C.; Yu, S.; Zinn, K.; Wang, J.; Zhang, L.; Jia, Y.; Kappes, J. C.; Barnes, S.; Kimberly, R. P.; Grizzle, W. E.; Zhang, H.-G. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 176(3):1375-1385; 2006.
102. Maiorana, A.; Fierabracci, A.; Cianfarani, S. Isolation and characterization of omental adipose progenitor cells in children: A potential tool to unravel the pathogenesis of metabolic syndrome. Horm. Res. 72(6):348-358; 2009.
103. Martens, T. P.; See, F.; Schuster, M. D.; Sondermeijer, H. P.; Hefti, M. M.; Zannettino, A.; Gronthos, S.; Seki, T.; Itescu, S. Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl 1):18-22; 2006.
104. Martin, P. J.; Uberti, J. P.; Soiffer, R. J.; Klingemann, H.; Waller, E. K.; Daly, A. S.; Herrmann, R. P.; Kebriaei, P. Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: Results of a randomized, placebo-controlled, multicenter phase III trial in GVHD. Biol. Blood Marrow Transplant. 16(2):S169-S170; 2010.
105. Mathivanan, S.; Ji, H.; Simpson, R. J. Exosomes: Extracellular organelles important in intercellular communication. J. Proteomics 73(10):1907-1920; 2010.
106. Mathivanan, S.; Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9(21):4997-5000; 2009.
107. Meckes, D. G. Jr.; Raab-Traub, N. Microvesicles and viral infection. J. Virol. 85(24):12844-12854; 2011.
108. Merchant, M. L.; Powell, D. W.; Wilkey, D. W.; Cummins, T. D.; Deegens, J. K.; Rood, I. M.; McAfee, K. J.; Fleischer, C.; Klein, E.; Klein, J. B. Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics Clin. Appl. 4(1):84-96; 2010.
109. Miksa, M.; Wu, R.; Dong, W.; Das, P.; Yang, D.; Wang, P. Dendritic cell-derived exosomes containing milk fat globule epidermal growth factor-factor VIII attenuate proinflammatory responses in sepsis. Shock 25(6):586-593; 2006.
110. Miksa, M.; Wu, R.; Dong, W.; Komura, H.; Amin, D.; Ji, Y.; Wang, Z.; Wang, H.; Ravikumar, T. S.; Tracey, K. J.; Wang, P. Immature dendritic cell-derived exosomes rescue septic animals via milk fat globule epidermal growth factor-factor VIII. J. Immunol. 183(9):5983-5990; 2009.
111. Milanesi, A.; Lee, J.-W.; Li, Z.; Da Sacco, S.; Villani, V.; Cervantes, V.; Perin, L.; Yu, J. S. β-Cell regeneration mediated by human bone marrow mesenchymal stem cells. PLoS One 7(8):e42177; 2012.
112. Mills, C. Osiris Therapeutics announces preliminary results for Prochymal phase III GvHD trials; 2009. Available from http://investor.osiris.com/releasedetail.cfm?ReleaseID=407404
113. Mokarizadeh, A.; Delirezh, N.; Morshedi, A.; Mosayebi, G.; Farshid, A.-A.; Mardani, K. Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling. Immunol. Lett. 147(1-2):47-54; 2012.
114. Monleon, I.; Martinez-Lorenzo, M. J.; Monteagudo, L.; Lasierra, P.; Taules, M.; Iturralde, M.; Pineiro, A.; Larrad, L.; Alava, M. A.; Naval, J.; Anel, A. Differential secretion of Fas ligand-or APO2 ligand/TNF-related apoptosisinducing ligand-carrying microvesicles during activationinduced death of human T cells. J. Immunol. 167(12): 6736-6744; 2001.
115. Montecalvo, A.; Shufesky, W. J.; Stolz, D. B.; Sullivan, M. G.; Wang, Z.; Divito, S. J.; Papworth, G. D.; Watkins, S. C.; Robbins, P. D.; Larregina, A. T.; Morelli, A. E. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J. Immunol. 180(5):3081-3090; 2008.
116. Morse, M. A.; Garst, J.; Osada, T.; Khan, S.; Hobeika, A.; Clay, T. M.; Valente, N.; Shreeniwas, R.; Sutton, M. A.; Delcayre, A.; Hsu, D. H.; Le Pecq, J. B.; Lyerly, H. K. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med. 3(1): 9; 2005.
117. Moskovich, O.; Fishelson, Z. Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex. J. Biol. Chem. 282(41):29977-29986; 2007.
118. Muller-Ehmsen, J.; Krausgrill, B.; Burst, V.; Schenk, K.; Neisen, U. C.; Fries, J. W. U.; Fleischmann, B. K.; Hescheler, J.; Schwinger, R. H. G. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J. Mol. Cell. Cardiol. 41(5):876-884; 2006.
119. Muraglia, A.; Cancedda, R.; Quarto, R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 113(Pt 7):1161-1166; 2000.
120. Nadri, S.; Soleimani, M. Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid. Cytotherapy 9(8):729-737; 2007.
121. Nauta, A. J.; Kruisselbrink, A. B.; Lurvink, E.; Willemze, R.; Fibbe, W. E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocytederived dendritic cells. J. Immunol. 177(4):2080-2087; 2006.
122. Nazarenko, I.; Rana, S.; Baumann, A.; McAlear, J.; Hellwig, A.; Trendelenburg, M.; Lochnit, G.; Preissner, K. T.; Zoller, M. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 70(4):1668-1678; 2010.
123. Nolte-’t Hoen, E. N. M.; Buschow, S. I.; Anderton, S. M.; Stoorvogel, W.; Wauben, M. H. M. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 113(9):1977-1981; 2009.
124. Nolte-’t Hoen, E. N. M.; van der Vlist, E. J.; Aalberts, M.; Mertens, H. C. H.; Bosch, B. J.; Bartelink, W.; Mastrobattista, E.; van Gaal, E. V. B.; Stoorvogel, W.; Arkesteijn, G. J. A.; Wauben, M. H. M. Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles. Nanomedicine 8(5):712-720; 2012.
125. Patki, S.; Kadam, S.; Chandra, V.; Bhonde, R. Human breast milk is a rich source of multipotent mesenchymal stem cells. Hum. Cell 23(2):35-40; 2010.
126. Peche, H.; Heslan, M.; Usal, C.; Amigorena, S.; Cuturi, M. C. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76(10):1503-1510; 2003.
127. Penicka, M.; Widimsky, P.; Kobylka, P.; Kozak, T.; Lang, O. Images in cardiovascular medicine. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation 112(4):63-65; 2005.
128. Phinney, D. G. Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy. J. Cell. Biochem. 113(9):2806-2812; 2012.
129. Poutsiaka, D. D.; Schroder, E. W.; Taylor, D. D.; Levy, E. M.; Black, P. H. Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages. J. Immunol. 134(1):138-144; 1985.
130. Qazi, K. R.; Gehrmann, U.; Domange Jordo, E.; Karlsson, M. C. I.; Gabrielsson, S. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood 113(12):2673-2683; 2009.
131. Qazi, K. R.; Torregrosa Paredes, P.; Dahlberg, B.; Grunewald, J.; Eklund, A.; Gabrielsson, S. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax 65(11):1016-1024; 2010.
132. Quah, B. J. C.; O’Neill, H. C. Mycoplasma contaminants present in exosome preparations induce polyclonal B cell responses. J. Leukoc. Biol. 82(5):1070-1082; 2007.
133. Quarto, R.; Mastrogiacomo, M.; Cancedda, R.; Kutepov, S. M.; Mukhachev, V.; Lavroukov, A.; Kon, E.; Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344(5): 385-386; 2001.
134. Rackham, C. L.; Dhadda, P. K.; Chagastelles, P. C.; Simpson, S. J. S.; Dattani, A. A.; Bowe, J. E.; Jones, P. M.; King, A. J. F. Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice. Cytotherapy 15(4):449-459; 2013.
135. Raposo, G.; Nijman, H. W.; Stoorvogel, W.; Liejendekker, R.; Harding, C. V.; Melief, C. J.; Geuze, H. J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183(3):1161-1172; 1996.
136. Rasmusson, I.; Le Blanc, K.; Sundberg, B.; Ringden, O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand. J. Immunol. 65(4):336-343; 2007.
137. Rasmusson, I.; Ringden, O.; Sundberg, B.; Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76(8):1208-1213; 2003.
138. Raynaud, C. M.; Rafii, A. The necessity of a systematic approach for the use of MSCs in the clinical setting. Stem Cells Int. 2013:892340; 2013.
139. Ren, G.; Chen, X.; Dong, F.; Li, W.; Ren, X.; Zhang, Y.; Shi, Y. Concise review: Mesenchymal stem cells and translational medicine: Emerging issues. Stem. Cells Transl. Med. 1(1):51-58; 2012.
140. Ren, G.; Su, J.; Zhang, L.; Zhao, X.; Ling, W.; L’Huillie, A.; Zhang, J.; Lu, Y.; Roberts, A. I.; Ji, W.; Zhang, H.; Rabson, A. B.; Shi, Y. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27(8):1954-1962; 2009.
141. Ren, G.; Zhang, L.; Zhao, X.; Xu, G.; Zhang, Y.; Roberts, A. I.; Zhao, R. C.; Shi, Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2(2):141-150; 2008.
142. Ringden, O.; Keating, A. Mesenchymal stromal cells as treatment for chronic GVHD. Bone Marrow Transplant. 46(2):163-164; 2011.
143. Sadallah, S.; Eken, C.; Schifferli, J. A. Ectosomes as modulators of inflammation and immunity. Clin. Exp. Immunol. 163(1):26-32; 2011.
144. Sarugaser, R.; Lickorish, D.; Baksh, D.; Hosseini, M. M.; Davies, J. E. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23(2):220-229; 2005.
145. Sato, K.; Ozaki, K.; Oh, I.; Meguro, A.; Hatanaka, K.; Nagai, T.; Muroi, K.; Ozawa, K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109(1):228-234; 2007.
146. Scudellari, M. The little cell that could. Scientist 26(7): 67-69; 2012.
147. Segura, E.; Nicco, C.; Lombard, B.; Veron, P.; Raposo, G.; Batteux, F.; Amigorena, S.; Thery, C. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106(1):216-223; 2005.
148. Shih, D. T.; Lee, D. C.; Chen, S. C.; Tsai, R. Y.; Huang, C. T.; Tsai, C. C.; Shen, E. Y.; Chiu, W. T. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 23(7):1012-1020; 2005.
149. Spaggiari, G. M.; Capobianco, A.; Becchetti, S.; Mingari, M. C.; Moretta, L. Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107(4):1484-1490; 2006.
150. Subra, C.; Laulagnier, K.; Perret, B.; Record, M. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 89(2):205-212; 2007.
151. Sun, L.; Akiyama, K.; Zhang, H.; Yamaza, T.; Hou, Y.; Zhao, S.; Xu, T.; Le, A.; Shi, S. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27(6): 1421-1432; 2009.
152. Sun, L.; Wang, D.; Liang, J.; Zhang, H.; Feng, X.; Wang, H.; Hua, B.; Liu, B.; Ye, S.; Hu, X.; Xu, W.; Zeng, X.; Hou, Y.; Gilkeson, G. S.; Silver, R. M.; Lu, L.; Shi, S. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 62(8):2467-2475; 2010.
153. Szajnik, M.; Czystowska, M.; Szczepanski, M. J.; Mandapathil, M.; Whiteside, T. L. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One 5(7): e11469; 2010.
154. Taylor, D. D.; Akyol, S.; Gercel-Taylor, C. Pregnancyassociated exosomes and their modulation of T cell signaling. J. Immunol. 176(3):1534-1542; 2006.
155. Taylor, D. D.; Gercel-Taylor, C. Exosomes/microvesicles: Mediators of cancer-associated immunosuppressive microenvironments. Semin. Immunopathol. 33(5):441-454; 2011.
156. Tetta, C.; Bruno, S.; Fonsato, V.; Deregibus, M. C.; Camussi, G. The role of microvesicles in tissue repair. Organogenesis 7(2):105-115; 2011.
157. Theise, N. D. Stem cell research: Elephants in the room. Mayo Clin. Proc. 78(8):1004-1009; 2003.
158. Thery, C.; Amigorena, S.; Raposo, G.; Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 30:3.22.1-3.22.29; 2006.
159. Thery, C.; Duban, L.; Segura, E.; Veron, P.; Lantz, O.; Amigorena, S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3(12): 1156-1162; 2002.
160. Thery, C.; Ostrowski, M.; Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9(8):581-593; 2009.
161. Thirabanjasak, D.; Tantiwongse, K.; Thorner, P. S. Angiomyeloproliferative lesions following autologous stem cell therapy. J. Am. Soc. Nephrol. 21(7):1218-1222; 2010.
162. Timmers, L.; Lim, S. K.; Arslan, F.; Armstrong, J. S.; Hoefer, I. E.; Doevendans, P. A.; Piek, J. J.; El Oakley, R. M.; Choo, A.; Lee, C. N.; Pasterkamp, G.; de Kleijn, D. P. V. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 1(2):129-137; 2007.
163. Timmers, L.; Lim, S. K.; Hoefer, I. E.; Arslan, F.; Lai, R. C.; van Oorschot, A. A. M.; Goumans, M. J.; Strijder, C.; Sze, S. K.; Choo, A.; Piek, J. J.; Doevendans, P. A.; Pasterkamp, G.; de Kleijn, D. P. V. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 6(3): 206-214; 2011.
164. Traggiai, E.; Volpi, S.; Schena, F.; Gattorno, M.; Ferlito, F.; Moretta, L.; Martini, A. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 26(2): 562-569; 2008.
165. Tyndall, A. Successes and failures of stem cell transplantation in autoimmune diseases. Hematology Am. Soc. Hematol. Educ. Program 2011:280-284; 2011.
166. Urban, V. S.; Kiss, J.; Kovacs, J.; Gocza, E.; Vas, V.; Monostori, E.; Uher, F. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26(1):244-253; 2008.
167. Utsugi-Kobukai, S.; Fujimaki, H.; Hotta, C.; Nakazawa, M.; Minami, M. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunol. Lett. 89(2-3):125-131; 2003
168. van der Pol, E.; Hoekstra, A. G.; Sturk, A.; Otto, C.; van Leeuwen, T. G.; Nieuwland, R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J. Thromb. Haemost. 8(12):2596-2607; 2010
169. van Dommelen, S. M.; Vader, P.; Lakhal, S.; Kooijmans, S. A. A.; van Solinge, W. W.; Wood, M. J. A.; Schiffelers, R. M. Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 161(2):635-644; 2012.
170. Veriter, S.; Gianello, P.; Igarashi, Y.; Beaurin, G.; Ghyselinck, A.; Aouassar, N.; Jordan, B.; Gallez, B.; Dufrane, D. Improvement of subcutaneous bioartificial pancreas vascularization and function by co-encapsulation of pig islets and mesenchymal stem cells in primates. Cell Transplant. 23(11):1349-1364; 2014.
171. Veron, P.; Segura, E.; Sugano, G.; Amigorena, S.; Thery, C. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol. Dis. 35(2): 81-88; 2005.
172. Viaud, S.; Terme, M.; Flament, C.; Taieb, J.; Andre, F.; Novault, S.; Escudier, B.; Robert, C.; Caillat-Zucman, S.; Tursz, T.; Zitvogel, L.; Chaput, N. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: A role for NKG2D ligands and IL-15R alpha. PLoS One 4(3):e4942; 2009.
173. Wakitani, S.; Imoto, K.; Yamamoto, T.; Saito, M.; Murata, N.; Yoneda, M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 10(3):199-206; 2002.
174. Wang, H. S.; Hung, S. C.; Peng, S. T.; Huang, C. C.; Wei, H. M.; Guo, Y. J.; Fu, Y. S.; Lai, M. C.; Chen, C. C. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 22(7):1330-1337; 2004.
175. Wieckowski, E. U.; Visus, C.; Szajnik, M.; Szczepanski, M. J.; Storkus, W. J.; Whiteside, T. L. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J. Immunol. 183(6):3720-3730; 2009.
176. Wolfers, J.; Lozier, A.; Raposo, G.; Regnault, A.; Thery, C.; Masurier, C.; Flament, C.; Pouzieux, S.; Faure, F.; Tursz, T.; Angevin, E.; Amigorena, S.; Zitvogel, L. Tumorderived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7(3):297-303; 2001.
177. Yamaza, T.; Kentaro, A.; Chen, C.; Liu, Y.; Shi, Y.; Gronthos, S.; Wang, S.; Shi, S. Immunomodulatory properties of stem cells from human exfoliated deciduous teeth. Stem Cell Res. Ther. 1(1):5; 2010.
178. Yang, C.; Robbins, P. D. The roles of tumor-derived exosomes in cancer pathogenesis. Clin. Dev. Immunol. 2011:842849; 2011.
179. Yang, X.; Meng, S.; Jiang, H.; Chen, T.; Wu, W. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis. Scand. J. Gastroenterol. 45(10):1168-1177; 2010.
180. Yeo, R. W.; Lai, R. C.; Zhang, B.; Tan, S. S.; Yin, Y.; Teh, B. J.; Lim, S. K. Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery. Adv. Drug Deliv. Rev. 65(3):336-341; 2013.
181. Yi, T.; Song, S. U. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch. Pharm. Res. 35(2):213-221; 2012.
182. Youd, M.; Blickarz, C.; Woodworth, L.; Touzjian, T.; Edling, A.; Tedstone, J.; Ruzek, M.; Tubo, R.; Kaplan, J.; Lodie, T. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin. Exp. Immunol. 161(1):176-186; 2010.
183. Zappia, E.; Casazza, S.; Pedemonte, E.; Benvenuto, F.; Bonanni, I.; Gerdoni, E.; Giunti, D.; Ceravolo, A.; Cazzanti, F.; Frassoni, F.; Mancardi, G.; Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106(5): 1755-1761; 2005.
184. Zhang, H. G.; Liu, C.; Su, K.; Su, K.; Yu, S.; Zhang, L.; Zhang, S.; Wang, J.; Cao, X.; Grizzle, W.; Kimberly, R. P. A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death. J. Immunol. 176(12):7385-7393; 2006.
185. Zheng, M.; Fang, H.; Tsuruoka, T.; Tsuji, T.; Sasaki, T.; Hakomori, S. Regulatory role of GM3 ganglioside in alpha 5 beta 1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. J. Biol. Chem. 268(3):2217-2222; 1993.
186. Zhou, K.; Zhang, H.; Jin, O.; Feng, X.; Yao, G.; Hou, Y.; Sun, L. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol. Immunol. 5(6):417-424; 2008.
187. Zhou, Y.; Day, A.; Haykal, S.; Keating, A.; Waddell, T. K. Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway. Cytotherapy 15(10):1195-1207; 2013.
188. Zuk, P.; M, M. Z.; P, P. A.; Ugarte, D. D.; Huang, J.; Mizuno, H.; Alfonso, Z.; Fraser, J.; Benhaim, P.; Hedrick, M. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13:4279-4295; 2002.